HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial
========================================================================================================================================================================

* Yan Song
* Ning Li
* Qun Li
* Xinjun Liang
* Shu Zhang
* Qingxia Fan
* Xianli Yin
* Zhixiang Zhuang
* Yunpeng Liu
* Jingdong Zhang
* Xiaoge Kou
* Haijun Zhong
* Xiaofei Wang
* Yiwei Dou
* Jing Huang